Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Arthur Daban"'
Autor:
Maxime Fontanilles, Jean-David Heisbourg, Arthur Daban, Frederic Di Fiore, Louis-Ferdinand Pépin, Florent Marguet, Olivier Langlois, Cristina Alexandru, Isabelle Tennevet, Franklin Ducatez, Carine Pilon, Thomas Plichet, Déborah Mokbel, Céline Lesueur, Soumeya Bekri, Abdellah Tebani
Publikováno v:
Acta Neuropathologica Communications, Vol 12, Iss 1, Pp 1-13 (2024)
Abstract Monitoring tumor evolution and predicting survival using non-invasive liquid biopsy is an unmet need for glioblastoma patients. The era of proteomics and metabolomics blood analyzes, may help in this context. A case–control study was condu
Externí odkaz:
https://doaj.org/article/f5bfa411040d43f09377044de97d9048
Autor:
Arthur Daban, Ludivine Beaussire-Trouvay, Émilie Lévêque, Cristina Alexandru, Isabelle Tennevet, Olivier Langlois, Ovidiu Veresezan, Florent Marguet, Florian Clatot, Frédéric Di Fiore, Nasrin Sarafan-Vasseur, Maxime Fontanilles
Publikováno v:
Translational Oncology, Vol 42, Iss , Pp 101897- (2024)
Background: Liquid biopsy application is still challenging in glioblastoma patients and the usefulness of short-length DNA (slDNA) fragments is not established. The aim was to investigate slDNA concentration as a prognostic marker in unresected gliob
Externí odkaz:
https://doaj.org/article/f41d5629bae3487789a40aed28f0e274
Autor:
Arthur Daban, Cecile Gonnin, Yann-Alexandre Vano, Letuan Phan, Agnes lillo-Lelouet, Christine le Beller, Jacques Pouchot, Elizabeth Fabre, Laurence Weiss, Eric Tartour, Stephane Oudard, Marie-Agnès Dragon Durey, Audrey Simonaggio
Publikováno v:
Journal of Clinical Oncology. 40:2523-2523
2523 Background: Immune checkpoint inhibitors (ICIs), used alone or as a combination are standard of care in many cancers. Generally well tolerated, they can generate immune-related adverse events (irAEs). No biomarkers are available to identify pati